3.53MMarket Cap-0.34P/E (TTM)
0.678High0.583Low154.53KVolume0.678Open0.689Pre Close96.79KTurnover9.74%Turnover RatioLossP/E (Static)6.03MShares6.00052wk High-2.47P/B928.60KFloat Cap0.45052wk Low--Dividend TTM1.59MShs Float6.000Historical High--Div YieldTTM13.80%Amplitude0.450Historical Low0.626Avg Price1Lot Size
Channel Therapeutics Stock Forum
📊⚡️📊
📊⚡️📊
Benzinga· 2 mins ago
Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain
Chromocell Therapeutics (NYSE American: CHRO) has unveiled an injectable depot program using peripheral nerve blocks for post-operative pain treatment. The program leverages the company's NaV1.7 molecule, targeting a market of approximately 700,000 total knee replacements and 500,000 shoulder arthroplastiesperformed annually in the US. The company's drug has shown...
looking good for a decent run maybe 🤞
something brewing here maybe?
No comment yet